Reyin Lien
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Reyin Lien has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Jen-Fu Hsu
Division of Neonatology, Department of Pediatrics, Chang Gung Memorial Hospital Linkou Branch and School of Medicine, Chang Gung University, No. 5, Fuxing St., Guishan Dist., Taoyuan City 333, Taiwan, ROC
3 shared publicationsMing-Chou Chiang
Division of Neonatology, Department of Pediatrics, Chang Gung Memorial Hospital Linkou Branch and School of Medicine, Chang Gung University, No. 5, Fuxing St., Guishan Dist., Taoyuan City 333, Taiwan, ROC
3 shared publicationsRen-Huei Fu
2 shared publicationsShih-Ming Chu
Division of Neonatology, Department of Pediatrics, Chang Gung Memorial Hospital, School of Medicine, Chang Gung University, No. 5, Fu-Shing Street, Kwei-Shan, Taoyuan, Taiwan, ROC
2 shared publicationsC.-W. Lee
Chang Gung University of Science and Technology Department of Nursing Division of Basic Medical Sciences, and Chronic Diseases and Health Promotion Research Center Chiayi Taiwan
1 shared publication- Chien-Chung Lee
Department of Pediatrics, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan 33373, Taiwan
1 shared publication
Latest Publications
- Open Access
- 1 December 2020
- Published by Elsevier in Biomedical Journal
- Vol. 43 (6) , 498
Author reply to letter to editor “melatonin as fetal neuroprotection: Links and risks”
- 1 December 2020
- Published by Elsevier in Biomedical Journal
- Vol. 43 (6) , 498
Open AccessAuthor reply to letter to editor “melatonin as fetal neuroprotection: Links and risks”
- Open Access
- 1 June 2020
- Published by Elsevier in Biomedical Journal
- Vol. 43 (3) , 259-267
Neurocritical care of premature infants
- 1 June 2020
- Published by Elsevier in Biomedical Journal
- Vol. 43 (3) , 259-267
Open AccessNeurocritical care of premature infants
- Open Access
- 1 October 2018
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 59 (5) , 474-480
Renal replacement therapy in the neonatal intensive care unit
- 1 October 2018
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 59 (5) , 474-480
Open AccessRenal replacement therapy in the neonatal intensive care unit
- Open Access
- 1 June 2017
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 58 (3) , 270-277
Clinical Manifestations, Outcomes, and Etiologies of Perinatal Stroke in Taiwan: Comparisons between Ischemic, and Hemorrhagic Stroke Based on 10-year Experience in A Single Institute
- 1 June 2017
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 58 (3) , 270-277
Open AccessClinical Manifestations, Outcomes, and Etiologies of Perinatal Stroke in Taiwan: Comparisons between Ischemic, and Hemorrhagic Stroke Based on 10-year Experience in A Single Institute
- Open Access
- 1 December 2016
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 57 (6) , 541-543
Severe Hyponatremia Secondary to Peripherally Inserted Central Catheter in a Neonate
- 1 December 2016
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 57 (6) , 541-543
Open AccessSevere Hyponatremia Secondary to Peripherally Inserted Central Catheter in a Neonate
- 1 December 2014
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 47 (6) , 555-557
Community-associated methicillin-resistant Staphylococcus aureus necrotizing pneumonia in a healthy neonate
- 1 December 2014
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 47 (6) , 555-557
Community-associated methicillin-resistant Staphylococcus aureus necrotizing pneumonia in a healthy neonate
- Open Access
- 5 November 2014
- Published by Springer Nature in Nutrition Journal
- Vol. 13 (1) , 1-11
Stool fatty acid soaps, stool consistency and gastrointestinal tolerance in term infants fed infant formulas containing high sn-2 palmitate with or without oligofructose: a double-blind, randomized clinical trial
Formula-fed (FF) infants often have harder stools and higher stool concentrations of fatty acid soaps compared to breastfed infants. Feeding high sn-2 palmitate or the prebiotic oligofructose (OF) may soften stools, reduce stool soaps, and decrease fecal calcium loss. We investigated the effect of high sn-2 palmitate alone and in combination with OF on stool palmitate soap, total soap and calcium concentrations, stool consistency, gastrointestinal (GI) tolerance, anthropometrics, and hydration in FF infants. This double-blind trial randomized 165 healthy term infants 25–45 days old to receive Control formula (n = 54), formula containing high sn-2 palmitate (sn-2; n = 56), or formula containing high sn-2 palmitate plus 3 g/L OF (sn-2+OF; n = 55). A non-randomized human milk (HM)-fed group was also included (n = 55). The primary endpoint, stool composition, was determined after 28 days of feeding, and was assessed using ANOVA accompanied by pairwise comparisons. Stool consistency, GI tolerance and hydration were assessed at baseline, day 14 (GI tolerance only) and day 28. Infants fed sn-2 had lower stool palmitate soaps compared to Control (P =0.0028); while those fed sn-2+OF had reduced stool palmitate soaps compared to both Control and sn-2 (both P <0.0001). Stool total soaps and calcium were lower in the sn-2+OF group than either Control (P <0.0001) or sn-2 (P <0.0001). The HM-fed group had lower stool palmitate soaps, total soaps and calcium (P <0.0001 for each comparison) than all FF groups. The stool consistency score of the sn-2+OF group was lower than Control and sn-2 (P <0.0001), but higher than the HM-fed group (P <0.0001). GI tolerance was similar and anthropometric z-scores were <0.2 SD from the WHO growth standards in all groups, while urinary hydration markers were within normal range for all FF infants. Increasing sn-2 palmitate in infant formula reduces stool palmitate soaps. A combination of high sn-2 palmitate and OF reduces stool palmitate soaps, total soaps and calcium, while promoting softer stools. This study was registered on http://www.clinicaltrials.gov: number NCT02031003 .
- 5 November 2014
- Published by Springer Nature in Nutrition Journal
- Vol. 13 (1) , 1-11
Open AccessStool fatty acid soaps, stool consistency and gastrointestinal tolerance in term infants fed infant formulas containing high sn-2 palmitate with or without oligofructose: a double-blind, randomized clinical trial
Formula-fed (FF) infants often have harder stools and higher stool concentrations of fatty acid soaps compared to breastfed infants. Feeding high sn-2 palmitate or the prebiotic oligofructose (OF) may soften stools, reduce stool soaps, and decrease fecal calcium loss. We investigated the effect of high sn-2 palmitate alone and in combination with OF on stool palmitate soap, total soap and calcium concentrations, stool consistency, gastrointestinal (GI) tolerance, anthropometrics, and hydration in FF infants. This double-blind trial randomized 165 healthy term infants 25–45 days old to receive Control formula (n = 54), formula containing high sn-2 palmitate (sn-2; n = 56), or formula containing high sn-2 palmitate plus 3 g/L OF (sn-2+OF; n = 55). A non-randomized human milk (HM)-fed group was also included (n = 55). The primary endpoint, stool composition, was determined after 28 days of feeding, and was assessed using ANOVA accompanied by pairwise comparisons. Stool consistency, GI tolerance and hydration were assessed at baseline, day 14 (GI tolerance only) and day 28. Infants fed sn-2 had lower stool palmitate soaps compared to Control (P =0.0028); while those fed sn-2+OF had reduced stool palmitate soaps compared to both Control and sn-2 (both P <0.0001). Stool total soaps and calcium were lower in the sn-2+OF group than either Control (P <0.0001) or sn-2 (P <0.0001). The HM-fed group had lower stool palmitate soaps, total soaps and calcium (P <0.0001 for each comparison) than all FF groups. The stool consistency score of the sn-2+OF group was lower than Control and sn-2 (P <0.0001), but higher than the HM-fed group (P <0.0001). GI tolerance was similar and anthropometric z-scores were <0.2 SD from the WHO growth standards in all groups, while urinary hydration markers were within normal range for all FF infants. Increasing sn-2 palmitate in infant formula reduces stool palmitate soaps. A combination of high sn-2 palmitate and OF reduces stool palmitate soaps, total soaps and calcium, while promoting softer stools. This study was registered on http://www.clinicaltrials.gov: number NCT02031003 .
- Open Access
- 1 November 2014
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 20 (11) , O928-O935
Recurrent late-onset sepsis in the neonatal intensive care unit: incidence, clinical characteristics and risk factors
- 1 November 2014
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 20 (11) , O928-O935
Open AccessRecurrent late-onset sepsis in the neonatal intensive care unit: incidence, clinical characteristics and risk factors
- 15 October 2014
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 174 (4) , 543-550
Hemodynamic alterations recorded by electrical cardiometry during ligation of ductus arteriosus in preterm infants
This is a prospective study using non-invasive electrical cardiometry to measure hemodynamic changes during surgical ligation of patent ductus arteriosus (PDA) in very low birth weight (VLBW, ≤1500 g) infants. The aims of this study were to examine hemodynamic aberration caused by abrupt closure of a ductal shunting and to define factors that affect hemodynamic changes. Simultaneous measurements of heart rate (HR), stroke volume (SV), cardiac output (CO), and systemic vascular resistance (SVR) were collected at ten time points: 1 h prior to anesthesia, at the beginning of anesthesia, starting of surgery, immediately after PDA being ligated, and 1 h followed by 6, 12, 18, 24, and 48 h after the surgery. Thirty infants with gestational age of 27.7 ± 2.0 weeks and birth weight of 929 ± 280 g were studied. Upon sudden termination of ductal shunting, there was a significant decline in CO to 73 % of presurgery baseline. The deterioration in CO was associated with a decreased SV rather than HR. At the same time, there was an increase of SVR following ductal ligation. Magnitude of CO and SV reduction were higher in smaller infants (≤1 kg), and recovery was to a lesser degree in infants with more severe PDA. Conclusion: Reduced stroke volume and elevated vascular resistance contribute to the major hemodynamic aberrations in VLBW infants receiving PDA ligation surgery.
- 15 October 2014
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 174 (4) , 543-550
Hemodynamic alterations recorded by electrical cardiometry during ligation of ductus arteriosus in preterm infants
This is a prospective study using non-invasive electrical cardiometry to measure hemodynamic changes during surgical ligation of patent ductus arteriosus (PDA) in very low birth weight (VLBW, ≤1500 g) infants. The aims of this study were to examine hemodynamic aberration caused by abrupt closure of a ductal shunting and to define factors that affect hemodynamic changes. Simultaneous measurements of heart rate (HR), stroke volume (SV), cardiac output (CO), and systemic vascular resistance (SVR) were collected at ten time points: 1 h prior to anesthesia, at the beginning of anesthesia, starting of surgery, immediately after PDA being ligated, and 1 h followed by 6, 12, 18, 24, and 48 h after the surgery. Thirty infants with gestational age of 27.7 ± 2.0 weeks and birth weight of 929 ± 280 g were studied. Upon sudden termination of ductal shunting, there was a significant decline in CO to 73 % of presurgery baseline. The deterioration in CO was associated with a decreased SV rather than HR. At the same time, there was an increase of SVR following ductal ligation. Magnitude of CO and SV reduction were higher in smaller infants (≤1 kg), and recovery was to a lesser degree in infants with more severe PDA. Conclusion: Reduced stroke volume and elevated vascular resistance contribute to the major hemodynamic aberrations in VLBW infants receiving PDA ligation surgery.
- 9 December 2008
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 26 (05) , 357-360
Heliox as the Rescue Therapy for a Neonate with Congenital Tracheal Stenosis, Pulmonary Artery Sling, and Intracardiac Anomalies
Congenital tracheal stenosis (CTS) is a rare disease associated with high mortality and morbidity, especially if it is associated with intracardiac anomalies or vascular rings. Heliox, a “carrier gas” with low density, has been used in pediatric intensive care units for treating acute respiratory failure due to obstructive airway disease. Here we report a 3100-g, 39-week newborn with long-segment CTS complicated with a pulmonary artery sling and tetralogy of Fallot, to whom heliox was given as the rescue therapy during near-complete airway obstruction and cardiopulmonary failure. Although this patient finally died from failure of corrective surgery, our experience with heliox has suggested that its effects in improving oxygenation and eliminating CO2 can be a rescue strategy in a mechanically ventilated infant with severe airway obstruction.
- 9 December 2008
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 26 (05) , 357-360
Heliox as the Rescue Therapy for a Neonate with Congenital Tracheal Stenosis, Pulmonary Artery Sling, and Intracardiac Anomalies
Congenital tracheal stenosis (CTS) is a rare disease associated with high mortality and morbidity, especially if it is associated with intracardiac anomalies or vascular rings. Heliox, a “carrier gas” with low density, has been used in pediatric intensive care units for treating acute respiratory failure due to obstructive airway disease. Here we report a 3100-g, 39-week newborn with long-segment CTS complicated with a pulmonary artery sling and tetralogy of Fallot, to whom heliox was given as the rescue therapy during near-complete airway obstruction and cardiopulmonary failure. Although this patient finally died from failure of corrective surgery, our experience with heliox has suggested that its effects in improving oxygenation and eliminating CO2 can be a rescue strategy in a mechanically ventilated infant with severe airway obstruction.